Indian pharmaceutical sector faces new challenges in 2025, from UCPMP implementation to global dynamics and opportunities in ...
Private equity and venture capital exits in 2024 reached $24 billion, driven by public market sales and top exit deals.
Deal values have touched $36.14 billion from $25.24 billion in 2023—marking a 43.2 percent increase; volumes too saw a 24.4 ...
As we bid goodbye to 2024 and get busy in welcoming the New Year, it is crucial to look back on how the markets fared in the ...
Mankind Pharma has entered into a partnership with Innovent Biologics for exclusively licensing and commercialising ...
After a year of decline, M&A activity in India rebounded with an 18.2% increase, reaching $96.9 billion so far in 2024, ...